No abstract
Images in Thorax Solitary fibrous tumour of the pleura causing bulging of the thoracic wall in a 44-year-old man A 44-year-old male patient presented with right chest pain for 6 years, along with progressive swelling in the same region. He did not report fever, weight loss, trauma or previous surgery. On physical examination, a 5 cm focal bulge was observed in the right hemithorax just below and medial to the nipple (figure 1). Chest x-ray showed opacification of the anterior lower third of the right hemithorax (figure 2), which on CT scan corresponded to a heterogeneous mass, compressing the right lung parenchyma and the mediastinum, partially protruding through the chest wall (figure 3). These findings were confirmed by an MRI scan, which also showed that there were no signs of cardiac invasion (figure 4, online supplementary movies 1 and 2). A transparietal biopsy of the mass revealed a proliferative lesion with fusocellular areas. Immunohistochemical examination was compatible with solitary fibrous tumour of the pleura. Surgery was indicated and a heterogeneous pale mass measuring 12.5 cm in diameter was removed confirming the diagnosis (figure 5). Pathology showed an absence of rib or muscular infiltration, while the adjunct lung showed recent haemorrhage. Postoperative recovery was uneventful and the patient was discharged from the intensive care unit on the first postoperative day and from the hospital on the fifth postoperative day. Solitary fibrous tumour of the pleura is an infrequent tumour (5% of pleural neoplasms) originating from mesenchymal tissue and is benign in 80% of cases. 1 It affects both sexes equally and is not related to tobacco or asbestos. Its origin may be from the visceral pleura (80%) or from other regions with mesenchymal cellsdparietal pleura, pericardium, peritoneum or the tunica albuginea. It is usually asymptomatic, but tumours larger than 10 cm frequently cause non-specific symptoms such as cough, dyspnoea and thoracic pain. Rarely, it causes hypoglycaemia or hypertrophic osteoarthropathy. Malignancy criteria include abundant cellularity, more than four mitoses per 10 fields at high magnification, cytonuclear atypicality, large haemorrhage/necrosis areas, pleural effusion and invasion of adjacent structures. Treatment consists of complete resection when possible, or radiotherapy/chemotherapy in cases with malignant degeneration. 2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.